Horizon Pharma plc trades on NASDAQ with the ticker symbol "HZNP"
Horizon Pharma plc became a publicly traded company on September 19, 2014, the date of the closing of Horizon Pharma, Inc.’s acquisition of Vidara Therapeutics International plc. Horizon Pharma, Inc. became a publicly traded company on July 27, 2011.
CUSIP NUMBER: G4617B 105
ISIN NUMBER: IE00BQPVQZ61
The adjusted cost basis for Horizon Pharma plc is the September 18, 2014 closing price of Horizon Pharma, Inc. of USD $12.37.
The Company has determined that it is not required to file a Form 8937.
Horizon Pharma's fiscal year end is December 31.
No, Horizon Pharma does not offer a dividend reinvestment program.
Horizon’s transfer agent and registrar, Computershare, is responsible for maintaining all records of registered stockholders. They are available to resolve problems related to lost, destroyed or stolen certificates. Computershare can also facilitate changes of address or certificate holder information. If you are a Horizon stockholder, you own your shares directly (not through a broker) and need to change your records pertaining to the stock, please contact Computershare at the address and phone number below.
Computershare Investor Services
+353 1 216 3128 (phone)
+353 1 447 5571 (fax)
Sandyford Industrial Estate
Dublin 18, Ireland
+1 866 286-9155 (in the U.S.)
+1 732 491-0661 (outside the U.S.)
211 Quality Circle, Suite 210
College Station, TX 77845
Please submit your question using the form below.